Consensus formalisé: recommandations de pratiques cliniques pour la prise en charge de la migraine du patient adulte africain

Conclusion

Tableau  2: Migraine  avec  aura,  critères  diagnostiques  selon la

classification de l’IHS 2004

Références

La migraine est une affection qui peut toucher plus de 8% de la population africaine. Significativement invalidante, il est prioritaire d'apporter des recommandations claires, adaptées à l'exercice médical en Afrique, quant à son diagnostic et à sa prise en charge (médicamenteuse ou non).

Etat des connaissances actuelle sur le sujet

     Les études épidémiologiques rapportent que les migraines sont fréquentes dans la population adulte;

     De  nombreuses  options  thérapeutiques  permettent  de traiter les crises migraineuses.

Contribution de notre étude à la connaissance

  Etat  des  lieux  sur  les  données  épidémiologiques  enAfrique;

   Recommandations sur la prise en charge de la migraine, adaptées aux conditions en Afrique (en fonction de la disponibilité des traitements et de l'accès aux soins).

Conflits d’intérêts

Les auteurs ne déclarent aucun conflit d'intérêt.

Contributions des auteurs

Tous les auteurs ont contribué à la conduite de ce travail. Tous les auteurs déclarent également avoir lu et approuvé la version finale du manuscrit.

1.     Henry P, Auray JP, Gaudin AF, Dartigues JF, Duru G, Lanteri- Minet  M  et  al.  Prevalence  and  clinical  characteristics  of migraine  in  France.  Neurology.  2002  Jul  23;  59(2):  232-

7. PubMed | Google Scholar

2.     Lipton RB, Stewart WF. Prevalence and impact of migraine.

Neurol   Clin.   1997   Feb;   15(1):   1-13.PubMed | Google

Scholar

3.     Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D.

Age  and sex specific  incidence rates  of migraine with and without visual aura. Am J Epidemiol. 1991 Nov 15; 134(10):

1111-20. PubMed |Google Scholar

4.     Headache  Classification  Subcommittee  of  the  International Headache S. The International Classification of Headache Disorders:  2nd  edition.  Cephalalgia.  2004;  24  Suppl  1:  9-

160. Google Scholar

5.     Adoukonou T, Houinato D, Kankouan J, Makoutode M, Paraiso M, Tehindrazanarivelo A et al. Migraine among university students in Cotonou (Benin). Headache. 2009 Jun; 49(6): 887-

93. PubMed |Google Scholar

6.   Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence A

review of population-based studies. Neurology. 1994 Jun; 44(6

Suppl 4): S17-23. PubMed | Google Scholar

7.   Dent  W,  Spiss  H,  Helbok  R,  Matuja  W,  Scheunemann  S, Schmutzhard E. Prevalence of migraine in a rural area in South Tanzania:  a  door-to-door  survey.  Cephalalgia.  2004  Nov;

24(11): 960-6. PubMed |Google Scholar

Tableau  1: Migraine  sans  aura,  critères  diagnostiques  selon  la

classification de l’IHS 2004

8.    Ezeala-Adikaibe AB, Stella EO, Ikenna O, Ifeoma U. Frequency and pattern of headache among medical students at Enugu, South East Nigeria. Niger J Med. 2012 Apr-Jun; 21(2): 205-

8. PubMed | Google Scholar

9.   Lipton RB, Stewart WF. Migraine in the United States: a review of epidemiology and health care use. Neurology. 1993 Jun;

43(6 Suppl 3): S6-10. PubMed | Google Scholar

10.  Mengistu G, Alemayehu S. Prevalence and burden of primary headache disorders among a local community in Addis Ababa, Ethiopia.      J      J      Headache      Pain.      2013      Mar

28;14:30. PubMed | Google Scholar

11.  O'Brien  B,  Goeree  R,  Streiner  D.  Prevalence  of  migraine headache in Canada: a population-based survey. Int J Epidemiol.   1994   Oct;   23(5):   1020-6. PubMed | Google Scholar

12.  Takele GM, Tekle Haimanot R, Martelletti P. Prevalence and burden of primary headache in Akaki textile mill workers, Ethiopia.    J    Headache    Pain.    2008    Apr;    9(2):    119-

28. PubMed | Google Scholar

13.  Wahab KW, Ugheoke AJ. Migraine: prevalence and associated disability among Nigerian undergraduates. Can J Neurol Sci.

2009 Mar; 36(2): 216-21. PubMed | Google Scholar

14. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence   by   race.   Neurology.   1996   Jul;   47(1):   52-

9. PubMed | Google Scholar

15.  Clarke CE, MacMillan L, Sondhi S, Wells NE. Economic and social  impact  of  migraine.  QJM.  1996  Jan;  89(1):  77-

84. PubMed | Google Scholar

16. Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity Disability, pain intensity, and attack frequency and duration. Neurology.      1994      Jun;      44(6      Suppl      4):      S24-

39. PubMed | Google Scholar

17.  Von Korff M, Stewart WF, Simon DJ, Lipton RB. Migraine and reduced work performance: a population-based diary study. Neurology.   1998   Jun;   50(6):   1741-5. PubMed | Google Scholar

18.  Wong TW, Wong KS, Yu TS, Kay R. Prevalence of migraine and other  headaches  in  Hong  Kong.  Neuroepidemiology.  1995;

14(2): 82-91. PubMed | Google Scholar

 19.  Jelsma  J,  Mielke  J,  Powell  G,  De  Weerdt  W,  De  Cock  P.

Disability in an urban black community in Zimbabwe. Disabil Rehabil.  2002  Nov  10;  24(16):  851-9. PubMed | Google Scholar

 20.  Ferrari MD. Migraine. Lancet. 1998 Apr 4; 351(9108): 1043-

51. PubMed | Google Scholar

 21.  Silberstein SD. Migraine and pregnancy. Neurol Clin. 1997 Feb;

15(1): 209-31. PubMed | Google Scholar

 22.  Cooney BS, Grossman RI, Farber RE, Goin JE, Galetta SL.

Frequency  of  magnetic  resonance  imaging  abnormalities  in patients with migraine. Headache. 1996 Nov-Dec; 36(10): 616-

21. PubMed | Google Scholar

 23.  Du Boulay GH, Ruiz JS, Rose FC, Stevens JM, Zilkha KJ. CT

changes associated with migraine. AJNR Am J Neuroradiol.

1983 May-Jun; 4(3): 472-3. PubMed | Google Scholar

24. Igarashi H, Sakai F, Kan S, Okada J, Tazaki Y. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia.   1991   May;   11(2):   69-74. PubMed | Google Scholar

 25.  Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N.

Association  between  migraine  and  stroke  in  a  large-scale epidemiological study of the United States. Arch Neurol. 1997

Apr; 54(4): 362-8. PubMed |Google Scholar

 26.  Welch KM, Helpern JA, Ewing JR, Robertson WM, D'Andrea G.

Biochemical   effects   of   cerebral   ischemia:   relevance   to migraine.  Cephalalgia.           1985        May;       5              Suppl      2:                   35-

42. PubMed | Google Scholar

 27.  Lanteri-Minet M,  Valade  D,  Geraud G, Lucas C, Donnet A.

Revised French guidelines for the diagnosis and management of migraine in adults and children. J Headache Pain. 2014 Jan

8;15:2. PubMed |Google Scholar

28.  Shapiro RE. Preventive treatment of migraine. Headache. 2012

Oct; 52 Suppl 2: 65-9. PubMed |Google Scholar

29.  Evers S. Treatment of migraine with prophylactic drugs. Expert

Opin       Pharmacother.      2008       Oct;       9(15):       2565-

73. PubMed | Google Scholar

30.  Silberstein SD. Treatment recommendations for migraine. Nat Clin Pract Neurol. 2008 Sep; 4(9): 482-9.PubMed | Google Scholar

31. Diamond S, Wenzel R. Practical approaches to migraine management.      CNS      Drugs.      2002;      16(6):      385-

403.PubMed | Google Scholar

32. Miller S. The acute and preventative treatment of episodic migraine. Ann Indian Acad Neurol. 2012 Aug; 15(Suppl 1): S33-9. PubMed | Google Scholar

33.  Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012

Jun; 52(6): 930-45. PubMed | Google Scholar

34.  Armstrong C, American Academy of N, American Headache S.

AAN/AHS update recommendations for migraine prevention in adults.   Am  Fam   Physician.   2013   Apr  15;   87(8):  584-

5. PubMed | Google Scholar

35.  Diener HC. Migraine prophylaxis: which drugs work and which ones  don't.  J  Gen  Intern  Med.  2013  Sep;  28(9):  1125-

6. PubMed | Google Scholar

36.  Firnhaber JM, Rickett K. Clinical inquiries What are the best prophylactic  drugs  for  migraine?  J  Fam  Pract.  2009  Nov;

58(11): 608-10. PubMed | Google Scholar

37.  Dekker F, Dieleman JP, Neven AK, Ferrari MD, Assendelft WJ.

Preventive   treatment   for   migraine   in   primary   care,   a population-based study in the Netherlands. Cephalalgia. 2013

Oct; 33(14): 1170-8.PubMed | Google Scholar

38.  Manzoni GC, Camarda C, Torelli P. Chronification of migraine:

what clinical strategies to combat it?. Neurol Sci. 2013 May; 34

Suppl 1: S57-60. PubMed | Google Scholar

39. Tfelt-Hansen   PC.   Evidence-based   guideline   update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society.     Neurology.     2013     Feb     26;     80(9):     869-

70. PubMed |Google Scholar

40.  Pascual J. Chronic migraine: treatment. Rev Neurol. 2012 Apr

10; 54 Suppl 2: S31-8. PubMed |Google Scholar

41.  Mercier A, Auger-Aubin I, Lebeau JP, Schuers M, Boulet P, Hermil JL et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Fam Pract. 2013; 14:

55. PubMed | Google Scholar

42.  Israil   A,   Ahmed   S,   Rahman   KM,   Uddin  MJ,   Dey   SK, Battacharjee M et al. Efficacy of amitriptyline, pizotifen and propranolol in the prevention of migraine. Mymensingh Med J.

2013 Jan; 22(1): 93-100.PubMed | Google Scholar

43.  Casucci G, Villani V, Cologno D, D'Onofrio F. Polytherapy for migraine prophylaxis. Neurol Sci. 2012 May; 33 Suppl 1: S147-

50. PubMed | Google Scholar

44.  Cassina M, Di Gianantonio E, Toldo I, Battistella PA, Clementi M. Migraine therapy during pregnancy and lactation. Expert Opin Drug Saf. 2010 Nov; 9(6): 937-48. PubMed | Google Scholar

45.  Hu Y, Guan X, Fan L, Jin L. Triptans in prevention of menstrual migraine: a systematic review with meta-analysis. J Headache Pain. 2013; 14: 7. PubMed | Google Scholar

46. Rizzoli P, Loder EW. Tolerance to the beneficial effects of prophylactic migraine drugs: a systematic review of causes and mechanisms.     Headache.     2011     Sep;     51(8):     1323-

35. PubMed | Google Scholar

47.  Smitherman TA, Walters AB, Maizels M, Penzien DB. The use of antidepressants for headache prophylaxis. CNS Neurosci Ther.

2011 Oct; 17(5): 462-9. PubMed | Google Scholar

48.  MacGregor  EA.  Menstruation,  sex  hormones,  and  migraine.

Neurol  Clin.  1997  Feb;  15(1):  125-41.PubMed | Google

Scholar

49.  Macgregor EA. Menstrual migraine: a clinical review. J Fam

Plann    Reprod   Health    Care.    2007    Jan;    33(1):     36-

47. PubMed | Google Scholar

50.  Silberstein S, Merriam G. Sex hormones and headache 1999 (menstrual migraine). Neurology.  1999; 53(4 Suppl 1): S3-

13. PubMed | Google Scholar

51. Somerville BW. Estrogen-withdrawal migraine I Duration of exposure required and attempted prophylaxis by premenstrual estrogen  administration.  Neurology.  1975  Mar;  25(3):  239-

44. PubMed | Google Scholar

52.  Becker  WJ.  Use  of  oral  contraceptives  in  patients  with migraine.    Neurology.    1999;    53(4    Suppl    1):    S19-

25.PubMed | Google Scholar

53.  Machado  RB,  Pereira  AP,  Coelho  GP,  Neri  L,  Martins  L, Luminoso D. Epidemiological and clinical aspects of migraine in users of combined oral contraceptives. Contraception. 2010

Mar; 81(3): 202-8. PubMed| Google Scholar

54. Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part

2.  Headache.  2006  Mar;  46(3):  365-86. PubMed | Google

Scholar

55.  Aube M. Migraine in pregnancy. Neurology. 1999; 53(4 Suppl

1): S26-8. PubMed | Google Scholar

56. Schoenen J. Migraine: genetic, physiopathological, and therapeutic innovations. Rev Med Liege. 1997 Feb; 52(2): 83-

8. PubMed | Google Scholar

57.  Silberstein  SD,  Merriam   GR.   Estrogens,  progestins,  and headache.      Neurology.      1991      Jun;      41(6):      786-

93.PubMed | Google Scholar

58.  Longe AC, Osuntokun BO. Prevalence of neurological disorders in Udo, a rural community in southern Nigeria. Trop Geogr Med. 1989 Jan; 41(1): 36-40.. PubMed | Google Scholar

59.  Mylek D. Migraine as one of the symptoms of food allergy. Pol Tyg Lek. 1992 Jan 20-27; 47(3-4): 89-91.PubMed | Google Scholar

60.  Robbins L. Precipitating factors in migraine: a retrospective review  of  494  patients.  Headache.  1994  Apr;  34(4):  214-

6. PubMed | Google Scholar

61. Peatfield RC. Relationships between food, wine, and beer- precipitated  migrainous  headaches.  Headache.  1995  Jun;

35(6): 355-7. PubMed | Google Scholar

62.  Weiss  HD,  Stern  BJ,  Goldberg  J.  Post-traumatic  migraine: chronic migraine precipitated by minor head or neck trauma. Headache.    1991    Jul;    31(7):    451-6. PubMed | Google Scholar

63.  Brewerton TD, George MS. A study of the seasonal variation of migraine.      Headache.      1990      Jul;      30(8):      511-

3. PubMed | Google Scholar

64.  Kelman L. The triggers or precipitants of the acute migraine attack.      Cephalalgia.      2007      May;      27(5):      394-

402. PubMed | Google Scholar

65. Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009 Jun;

25(5): 446-52. PubMed | Google Scholar

66.  Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012 Apr 24; 78(17):

1346-53. PubMed | Google Scholar

67.  Bryans R, Descarreaux M, Duranleau M, Marcoux H, Potter B, Ruegg R et al. Evidence-based guidelines for the chiropractic treatment of adults with headache. J Manipulative Physiol Ther.

2011 Jun; 34(5): 274-89. PubMed | Google Scholar